SREBF1-mediated SND1 transcriptional activation promotes prostate cancer progression via MTDH interaction through the SESN2/AMPK/mTOR axis

Yijie Tang(Zhejiang University), Ben Liu(Zhejiang Cancer Hospital), Liping Xie(First Affiliated Hospital Zhejiang University), Jiahe Yi(First Affiliated Hospital Zhejiang University), Yuqing Wu(Zhejiang University), Zixiang Liu(Zhejiang Cancer Hospital), Xuan Shu(Zhejiang Cancer Hospital), Lin Shen(Hunan Provincial Center for Disease Control and Prevention), Jiangfeng Li(First Affiliated Hospital Zhejiang University), Yufan Ying(Soochow University), Jindan Luo(First Affiliated Hospital Zhejiang University), Xiangyi Zheng(Tianjin University), Zhixiang Qi(First Affiliated Hospital Zhejiang University), Xueyou Ma(First Affiliated Hospital Zhejiang University)
Journal of Translational Medicine
August 7, 2025
10.1186/s12967-025-06762-2
Cited by 2

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>
|Cancer Science|2009|188